Korea United Pharm Inc. (KRX:033270)
South Korea
· Delayed Price · Currency is KRW 19,830
-110 (-0.55%)
At close: Mar 6, 2026
Korea United Pharm Revenue
Korea United Pharm had revenue of 39.95B KRW in the quarter ending September 30, 2015, with 6.10% growth. This brings the company's revenue in the last twelve months to 161.44B, up 8.00% year-over-year. In the year 2014, Korea United Pharm had annual revenue of 155.19B with 13.37% growth.
Revenue (ttm)
161.44B
Revenue Growth
+8.00%
P/S Ratio
1.81
Revenue / Employee
242.76M
Employees
665
Market Cap
291.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 155.19B | 18.30B | 13.37% |
| Dec 31, 2013 | 136.89B | 2.06B | 1.53% |
| Dec 31, 2012 | 134.83B | -10.62B | -7.30% |
| Dec 31, 2011 | 145.45B | 10.47B | 7.76% |
| Dec 31, 2010 | 134.98B | 15.89B | 13.35% |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
| Mar 31, 2007 | Pro | Pro | Pro |
| Mar 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hyundai Pharmaceutical | 108.14B |
| BNC Korea | 98.11B |
| JW Holdings | 935.51B |
| Huons | 602.21B |
| Boditech Med | 151.75B |
| CMG Pharmaceutical | 100.41B |
| Yungjin Pharm. | 158.79B |
| Suheung | 704.47B |